Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: Long-term results

Journal of Clinical Oncology

Volumn 15, Issue 9, 1997, Pages 3100-3110

  Clark, John R ^a   Busse, Paul M ^a   Norris Jr , Charles M ^a   Andersen, Janet W ^a   Dreyfuss, Arnon I ^a   Rossi, Renée M ^a   Poulin, Mark D ^a   Colevas, A Dimitrios ^a   Tishler, Roy B ^a   Costello, Rosemary ^a   Lucarini, James W ^a   Lucarini, Donna ^a   Thornhill, Lee ^a   Lackey, Melissa ^a   Peters, Edward ^a   Posner, Marshall R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; ARTICLE; BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; FOLLOW UP; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RELAPSE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030771178     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.9.3100     Document Type: Article

References (53)

1. Paccagnella A, Orlando A, Marchiori C, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppodidi Studio Sui Tumori Della Testa E Del Coloo. J Natl Cancer Inst 86:265-272, 1994
2. Department of Veteran's Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with laryngeal cancer. N Engl J Med 324:1685-1690, 1991
3. Lefebvre J-L, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-899, 1996
4. Spaulding MB, Fischer SG, Wolf GT, et al: Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 12:1592-1599, 1994
5. Depondt J, Gehanno P, Martin M, et al: Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 50:23-27, 1993 (suppl 2)
6. o disease. Semin Oncol 16:1-14, 1989 (suppl 6)
7. Kish JA, Ensley JF, Jacobs JR, et al: Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancer. Am J Clin Oncol 11:553-557, 1988
8. Urba SG, Forastierre AA, Wolf GT, et al: Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol 12:946-953, 1994
9. Taylor SG 4th, Murthy AK, Caldarelli DD, et al: Combined simultaneous cisplatin/fluorouracil chemotherapy course radiation in head and neck cancer. J Clin Oncol 7:846-856, 1989
10. Adelstein DJ, Sharan VM, Earle AS, et al: Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65:1685-1691, 1990
11. Browman GP, Cripps C, Hodson I, et al: Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 12:2648-2653, 1994
12. Merlano M, Vitale V, Rosso R, et al: Treatment of advanced squamous cell carinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115-1121, 1992
13. Haffty B, Son Y, Papac C, et al: Chemotherapy as an adjunct to radiation therapy in the treatment of squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 15:316, 1996 (abstr 893)
14. Jacobs C, Goffinet DR, Goffinet L, et al: Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 60:1178-1183, 1987
15. Urba SG, McLaughlin PW, Wolf GT, et al: Induction chemotherapy with carboplatin and 5-fluorouracil for organ preservation in patients with advanced head and neck cancer. Proc Am Soc Clin Oncol 13:910, 1994 (abstr)
16. Dreyfuss AI, Clark JR, Wright JE, et al: Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med 112:167-172, 1990
17. Busse P, Clark J, Beard C, et al: Primary site management following induction chemotherapy with cis-platin, 5-fluorouracil and leucovorin. Head Neck 15:413-418, 1993
18. American Joint Committee on Cancer: Manual for Staging of Cancer (ed 3). Philadelphia, PA, Lippincott, 1988
19. Wang CC, Blitzer PH, Suit HD: Twice-a-day radiation therapy for cancer of the head and neck. Cancer 55:2100-2104, 1985
20. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
21. Lo TC, Wiley AL Jr, Ansfield FJ: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgenol 126:229-235, 1976
22. Laccourrey O, Brasnu D, Bassot V, et al: Cisplatin-fluorouracil exclusive chemotherapy for T1-3N0 glottic squamous cell carcinoma complete clinical responders: 5-year results. J Clin Oncol 14:2331-2336, 1996
23. Rooney M, Kish J, Jacobs J, et al: Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55:1123-1128, 1985
24. Urba S, Forestiere A: Systemic therapy of head and neck carcinoma: Most effective agents and areas of controversy. Oncology 3:79-88, 1989
25. Clark JF, Fallon BG, Dreyfuss AI, et al: Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer. Semin Oncol 15:35-44, 1988 (suppl 3)
26. Ensley J, Kish J, Tapazoglou E, et al: Continued intensification of an alternating regimen in patients with advanced, untreated squamous cancers of the head and neck. Proc Am Soc Clin Oncol 7:154, 1988 (abstr 598)
27. Haines I, Bosl G, Pfister D, et al: Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer. J Clin Oncol 5:1594-1600, 1987
28. Forastiere AA, Natale RB, Takasugi BJ, et al: A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck. J Clin Oncol 5:190-196, 1987
29. Kramer A, Choksi A, Dimmery I, et al: Induction chemotherapy using cisplatin, bleomycin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 7:610, 1988 (abstr)
30. Scanlon KJ, Newman EM, Lu Y, et al: Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83:8923-8925, 1986
31. Scanlon KJ, Lu Y, Kashani SM, et al: Mechanisms for cisplatin-FUra synergism and cisplatin resistance in human ovarian carcinoma cells both in vitro and in vivo. Adv Exp Med Biol 244:127-135, 1988
32. Wennerberg J, Biorklund A, Trope C: The effect of cisplatin and fluorouracil on xenografted human squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 114:162-167, 1988
33. Trave F, Zakrzewski S, Petrelli N: Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin. NCI Monogr 5:165-170, 1987
34. Evans RM, Laskin JD, Hakala MT: Effects of excess folate and deoxyadenosine on the activity and site of action of 5-fluorouracil. Cancer Res 41:3288-3295, 1981
35. Houghton JA, Maroda SJ Jr, Phillips JO, et al: Biochemical determinants of responiveness to 5-fluorouracil and its derivatives in xenographs of human colorectal adenocarcinoma in mice. Cancer Res 41:144-149, 1981
36. Ullman B, Lee M, Martin DW Jr, et al: Cytotoxicity of 5-fluoro-2′-deoxyuridine: Requirement for reduced folate cofactors and antagonism by methotrexate. Proc Natl Acad Sci USA 75:980-983, 1978
37. Waxman S, Bruckner H: The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and alpha-tocopherol. Eur J Cancer Clin Oncol 18:685-692, 1982
38. Chéradame S, Etienne M, Fischel J, et al: Are physiologically reduced concentrations in tumors relevant for optimal FU efficacy? Experimental and clinical answers. Proc Am Assoc Cancer Res 37:366, 1996 (abstr 2500)
39. Cao S, Frank C, Rustum Y: Role of fluoropyrimidine schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma. J Natl Cancer Inst 88:430-436, 1996
40. Belliveau J, Posner M, Cummings F, et al: Clinical and pharmacokinetic study of cis-diammine dichloroplatinum administered as a continuous infusion. Cancer Treat Rep 70:1215-1227, 1986
41. Forastiere AA, Belliveau JF, Goren PG, et al: Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients. Cancer Res 48:3869-3874, 1988
42. Clark J, Fallon B, Dreyfus A, et al: Infusion cisplatin and 5-fluorouracil with methotrexate/leucovorin for advanced, previously untreated squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 7:153, 1988 (abstr)
43. Ervin TJ, Clark JR, Weichselbaum RR, et al: An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 5:10-20, 1987
44. Vokes EE, Schilsky RL, Weichselbaum RR, et al: Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for locally advanced head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 8:241-247, 1990
45. Vokes EE, Weichselbaum RR, Mick R, et al: Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 84:877-882, 1992
46. Schneider M, Etienne M, Milano G, et al: Phase II trial of cisplastin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: A pharmacokinetic and clinical survey. J Clin Oncol 13:1656-1662, 1995
47. Milano G, Etienne M, Renée N, et al: Relationship between fluorouracil systemic exposure and tumor response and patient survival. J Clin Oncol 12:1291-1295, 1994
48. Vokes E, Mick R, Kies M, et al: Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer. J Clin Oncol 14:1663-1671, 1996
49. Pfister D, Bajorin D, Motzer R, et al: Cisplatin, fluorouracil, and leucovorin: Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 120:89-95, 1994
50. Million RR, Cassissi NJ: Management of Head and Neck Cancer: A Multidisciplinary Approach (ed 2). Philadelphia, PA, Lippincott, 1994, p 913
51. Schuller DE, Metch B, Stein DW, et al: Preoperative chemotherapy in advanced resectable head and neck cancer - Final report of the Southwest Oncology Group. Laryngoscope 98:1205-1211, 1988
52. Jacobs C, Makuck R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 8:838-847, 1990
53. Al-Kourainy K, Kish J, Ensley J, et al: Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 59:233-238, 1987